IOVA Stock Price
Iovance Biotherapeutics (IOVA) - Stock price history
Stock price history for Iovance Biotherapeutics from 2010 to 2024.
Iovance Biotherapeutics Inc (IOVA) - InvestorPlace
Check out our IOVA stock analysis, current IOVA quote, charts, and historical prices for Iovance Biotherapeutics Inc stock.
Iovance Biotherapeutics, Inc. share price: IOVA Stock Price live today
Iovance Biotherapeutics, Inc. (IOVA) ; Buy. 90%Buy. 10%Hold. 0. 0%Sell ; Hold. 0 ; Current $10.46 ; Target $24.42 ; Technicals Summary. Sell. Neutral. Buy. Iovance ...
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price News
There's plenty of upside with this stock, but it might take a while to realize. Alex Carchidi Iovance Biotherapeutics (NASDAQ:IOVA) is a hot biotech stock for a ...
Iovance Biotherapeutics NasdaqGM:IOVA Stock Report
Price History & Performance ; Current Share Price, US$9.69 ; 52 Week High, US$18.33 ; 52 Week Low, US$4.29 ; Beta, 0.59.
Iovance Biotherapeutics Inc IOVA NASDAQ - Securities.io
Iovance Biotherapeutics Inc IOVA. NASDAQ ; Open. $12.22. Day range ; EPS. -$1.67. Average volume ; Revenue. $1.19M · Bid * Size.
Iovance Biotherapeutics Inc Share Price, IOVA Stock Price ... - Groww
Ltd. (Formerly known as Nextbillion Technology Pvt. Ltd) (CIN: U65100KA2016PTC092879) is a member of NSE & BSE with SEBI Registration no: INZ000301838, ...
Iovance Biotherapeutics stock price · IOVA share today - Bitpanda
Invest in Iovance Biotherapeutics (IOVA) on Bitpanda commission-free and with tight spreads! Follow the Iovance Biotherapeutics stock price today.
IOVA Stock Options Chain, Prices and News - Webull
Webull offers IOVA Ent Holdg (IOVA) historical stock prices, in-depth market analysis, NASDAQ: IOVA real-time stock quote data, in-depth charts, free IOVA ...
Iovance Biotherapeutics Inc, IOVA:NMQ summary - FT.com
On Thursday, Iovance Biotherapeutics Inc (IOVA:NMQ) closed at 8.59, 100.23% above the 52 week low of 4.29 set on Nov 14, 2023. 52-week range. Today. 4.29Nov 14 ...
Iovance Biotherapeutics Inc IOVA | US News Best Stocks
Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from 5.83% to 6.83%. Open An Account. View Disclosure.
IOVA Volume and Price Iovance Biotherapeutics - Market Chameleon
The opening auction price ticked up from the premarket to $8.63, on a much higher volume than typical for the last 30 days. However, the stock showed weakness ...
Iovance Biotherapeutics Inc 30-Y Financial Data - GuruFocus
Comprehensive and up-to-date Iovance Biotherapeutics Inc (IOVA) stock information, news and insights by GuruFocus ... Stock quotes are provided by QuoteMedia, Inc ...
IOVA Forecast — Price Target — Prediction for 2025 - TradingView
According to analysts, IOVA price target is 23.77 USD with a max estimate of 34.00 USD and a min estimate of 10.00 USD. Check if this forecast comes true in a ...
IOVA | Iovance Biotherapeutics Inc. Analyst Estimates & Ratings - WSJ
Iovance Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IOVA updated stock price target summary.
IOVA Stock Forecast & Price Target - ValueInvesting.io
The average stock forecast for Iovance Biotherapeutics Inc (IOVA) is 24.91 USD. This price target corresponds to an upside of 143.21%.
Iovance Biotherapeutics Inc. (IOVA) Stock Price, News and Catalysts
IOVA is a clinical-stage biopharmaceutical company focused on the development and commercialization of cell therapies as cancer immunotherapy products.
Iovance Biotherapeutics (IOVA) Stock Forecast & Analyst Ratings
Free Iovance Biotherapeutics (IOVA) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions.
Iovance Biotherapeutics Inc 2LB-FF:Frankfurt Stock Exchange - CNBC
Iovance Biotherapeutics Inc 2LB-FF:Frankfurt Stock Exchange · Open9.53 · Day High9.53 · Day Low9.53 · Prev Close9.92 · 52 Week High16.85 · 52 Week High Date03/04/24 ...
Iovance Biotherapeutics (IOVA) Stock Forecast and Price Target 2024
IOVA's current price target is $22.33. Learn why top analysts are making this stock forecast for Iovance Biotherapeutics at MarketBeat.